Pfizer Loses Trademark Suit Over Envacar In China

Law360, New York (December 21, 2004, 12:00 AM EST) -- U.S. drug maker Pfizer Inc has lost a drug trademark lawsuit it filed with the Beijing No.1 Intermediate People's Court at the end of September against China's State Administration for Industry and Commerce.

Pfizer had accused the administration of unfairly rejecting its application for a trademark registration in China for Envacar a drug used in treating high blood pressure. Starting in September 2001, the drug maker twice submitted an application to SAIC to register Envacar as the trademark for the high blood pressure drug.

However, SAIC...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.